Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: The KORA/MONICA Augsburg cohort study 1989-1998

European Journal of Epidemiology

Volumn 21, Issue 5, 2006, Pages 359-365

  Metzger, Marie Hélène ^a   Heier, Margit ^a   Mäki, Markku ^b   Bravi, Enzo ^c   Schneider, Andrea ^a   Löwel, Hannelore ^a   Illig, Thomas ^a   Schuppan, Detlef ^d,e   Wichmann, Heinz Erich ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c Eurospital   (Italy)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Celiac disease; Cohort studies; Mortality; Neoplasms; Tissue transglutaminase

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN A ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; RECOMBINANT ANTIBODY;

ADULT; AGE DISTRIBUTION; ANTIBODY BLOOD LEVEL; ARTICLE; CANCER; CANCER MORTALITY; CAUSE OF DEATH; CHRONIC LIVER DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GERMANY; HAZARD ASSESSMENT; HEALTH SURVEY; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; SEX RATIO;

ADULT; AGE DISTRIBUTION; AGED; CAUSE OF DEATH; COHORT STUDIES; FEMALE; GERMANY; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; NEOPLASMS; SEX DISTRIBUTION; TIME FACTORS; TRANSGLUTAMINASES;

EID: 33745876275     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-006-9002-4     Document Type: Article

References (30)

1. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000; 119: 234-242.
2. Korponay-Szabo IR, Sulkanen S, Halttunen T, Maurano F, Rossi M, Mazzarella G, Laurila K, Troncone R, Maki M. Tissue transglutaminase is the target in both rodent and primate tissues for celiac disease-specific autoantibodies. J Pediatr Gastroenterol Nutr 2000; 31: 520-527.
3. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797-801.
4. Dieterich W, Laag E, Schopper H, Volta U, Ferguson A, Gillett H, Riecken EO, Schuppan D. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998; 115: 1317-1321.
5. Blackwell PJ, Hill PG, Holmes GK. Autoantibodies to human tissue transglutaminase: Superior predictors of coeliac disease. Scand J Gastroenterol 2002; 37: 1282-1285.
6. Sblattero D, Berti I, Trevisiol C, Marzari R, Tommasini A, Bradbury A, Fasano A, Ventura A, Not T. Human recombinant tissue transglutaminase ELISA: An innovative diagnostic assay for celiac disease. Am J Gastroenterol 2000; 95: 1253-1257.
7. Peracchi M, Trovato C, Longhi M, Gasparin M, Conte D, Tarantino C, Prati D, Bardella MT. Tissue transglutaminase antibodies in patients with end-stage heart failure. Am J Gastroenterol 2002; 97: 2850-2854.
8. Vecchi M, Folli C, Donato MF, Formenti S, Arosio E, de Franchis R. High rate of positive anti-tissue transglutaminase antibodies in chronic liver disease. Role of liver decompensation and of the antigen source. Scand J Gastroenterol 2003; 38: 50-54.
9. Reeves GE, Burns C, Hall ST, Gleeson M, Lemmert K, Clancy RL. The measurement of IgA and IgG transglutaminase antibodies in celiac disease: A comparison with current diagnostic methods. Pathology 2000; 32: 181-185.
10. Sardy M, Odenthal U, Karpati S, Paulsson M, Smyth N. Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy. Clin Chem 1999; 45: 2142-2149.
11. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002; 346: 180-188.
12. WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988; 41: 105-114.
13. Hense H-W, Filipiak B, Doering A, Stieber J, Liese A, Keil U. Ten-Year trends of Cardiovascular Risk Factors in the MONICA Augsburg Region in Southern Germany. Results from the 1984/1985, 1989/1990, and 1994/1995 Surveys. CVD Prev 1998; 1: 318-327.
14. Parnell ND, Ciclitira PJ. Review article: Coeliac disease and its management. Aliment Pharmacol Ther 1999; 13: 1-13.
15. Holmes GK, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease-effect of a gluten free diet. Gut 1989; 30: 333-338.
16. Loftus CG, Loftus EV Jr. Cancer risk in celiac disease. Gastroenterology 2002; 123: 1726-1729.
17. Logan RF, Rifkind EA, Turner ID, Ferguson A. Mortality in celiac disease. Gastroenterology 1989; 97: 265-271.
18. Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 2003; 163: 1566-1572.
19. Corrao G, Corazza GR, Bagnardi V, Brusco G, Ciacci C, Cottone M, Sategna GC, Usai P, Cesari P, Pelli MA, Loperfido S, Volta U, Calabro A, Certo M. Mortality in patients with coeliac disease and their relatives: A cohort study. Lancet 2001; 358: 356-361.
20. Catassi C, Fabiani E, Corrao G, Barbato M, De Renzo A, Carella AM, Gabrielli A, Leoni P, Carroccio A, Baldassarre M, Bertolani P, Caramaschi P, Sozzi M, Guariso G, Volta U, Corazza GR. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002; 287: 1413-1419.
21. Nielsen OH, Jacobsen O, Pedersen ER, Rasmussen SN, Petri M, Laulund S, Jarnum S. Non-tropical sprue. Malignant diseases and mortality rate. Scand J Gastroenterol 1985; 20: 13-18.
22. Holmes GK. Celiac disease and malignancy. J Pediatr Gastroenterol Nutr 1997; 24: S20-S23.
23. Marsh MN. Is celiac disease (gluten sensitivity) a pre-malignant disorder? J Pediatr Gastroenterol Nutr 1997; 24: S25-S27.
24. Csizmadia CG, Mearin ML, von Blomberg BM, Brand R, Verloove-Vanhorick SP. An iceberg of childhood coeliac disease in the Netherlands. Lancet 1999; 353: 813-814.
25. Maki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, Ilonen J, Laurila K, Dahlbom I, Hansson T, Hopfl P, Knip M. Prevalence of coeliac disease among children in Finland. N Engl J Med 2003; 348: 2517-2524.
26. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, Elitsur Y, Green PHR, Guandalini S, Hill ID, Pietzak M, Ventura A, Thorpe M, Kryszak D, Fornaroli F, Wasserman SS, Murray JA, Horvath K. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States - A large multicenter study. Arch Intern Med 2003; 163: 286-292.
27. Leffler D, Saha S, Farrell RJ. Celiac disease. Am J Manag Care 2003; 9: 825-831.
28. Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A. Coeliac disease-associated disorders and survival. Gut 1994; 35: 1215-1218.
29. Löwel H, Meisinger C, Heier M, Hörmann A, Kuch B, Gostomzyk J, Koenig W. Sex specific trends of sudden cardiac death and acute myocardial infarction: Results of the population-based KORA/MONICA-Augsburg Register 1985-1998. Deutsche Medizinische Wochenschrift 2002; 127: 2311-2316.
30. Döring A, Filipiak B, Stieber J, Keil U. Trends in alcohol intake in a southern German population from 1984-1985 to 1989-1990: Results of the MONICA Project Augsburg. J Stud Alcohol 1993; 54: 745-749.